[Use of chemotherapy and immunotherapy in the treatment of patients with acute myeloblastic leukemia (proceedings)].
作者信息
Russell J A, Powles R L
出版信息
Minerva Med. 1977 Oct 27;68(51):3528-32.
PMID:270618
Abstract
摘要
相似文献
1
[Use of chemotherapy and immunotherapy in the treatment of patients with acute myeloblastic leukemia (proceedings)].[化疗和免疫疗法在急性髓细胞白血病患者治疗中的应用（会议记录）]
Minerva Med. 1977 Oct 27;68(51):3528-32.
2
Immunotherapy of leukemia and lymphoma.白血病和淋巴瘤的免疫疗法。
Semin Hematol. 1978 Apr;15(2):181-203.
3
Chemo-immunotherapy versus chemotherapy in acute myeloid leukemia. Preliminary results.急性髓系白血病中化学免疫疗法与化学疗法的比较。初步结果。
Biomedicine. 1976 Dec 5;25(9):318.
4
The effect of immunotherapy on survival of patients with acute myelogenous leukaemia after relapse.免疫疗法对急性髓性白血病复发后患者生存的影响。
Haematologia (Budap). 1976;10(1):5-9.
5
The role of immunotherapy in acute myelogenous leukemia.免疫疗法在急性髓性白血病中的作用。
Arch Intern Med. 1983 Sep;143(9):1726-31.
6
[Prolonged survival in adults with acute myeloid leukemia treated with BCG immunotherapy].[接受卡介苗免疫疗法治疗的成年急性髓系白血病患者的长期生存情况]
Nouv Presse Med. 1982 Dec 4;11(49):3637-9.
7
Chemotherapy and immunotherapy interspersion: clinical studies in acute myeloblastic leukaemia.化疗与免疫疗法交替应用：急性髓细胞白血病的临床研究
Recent Results Cancer Res. 1977(62):90-4. doi: 10.1007/978-3-642-81174-6_13.
8
Immunotherapy of acute myelogenous leukemia in man.人类急性髓性白血病的免疫疗法。
Natl Cancer Inst Monogr. 1973 Dec;39:243-7.
9
Modifying the biological response to acute myeloid leukemia I. BCG, allogeneic leukemic cells and spontaneous cytotoxicity.改变对急性髓细胞白血病的生物学反应。I. 卡介苗、同种异体白血病细胞与自发细胞毒性。
Anticancer Res. 1983 Jul-Aug;3(4):239-41.
10
Phase II trial of active immunotherapy of acute myeloid leukemia.急性髓系白血病主动免疫疗法的II期试验
Biomedicine. 1975 Sep 10;23(7):291-3.
Zotero 插件